These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20046771)

  • 1. In vitro Evaluation of the Effect of Combination of Hydrophilic and Hydrophobic Polymers on Controlled Release Zidovudine Matrix Tablets.
    Ganesh S; Radhakrishnan M; Ravi M; Prasannakumar B; Kalyani J
    Indian J Pharm Sci; 2008; 70(4):461-5. PubMed ID: 20046771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of zidovudine: influence of combination of hydrophilic and hydrophobic matrix formers.
    Kuksal A; Tiwary AK; Jain NK; Jain S
    AAPS PharmSciTech; 2006 Jan; 7(1):E1. PubMed ID: 16584139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release matrix tablets of zidovudine: effect of formulation variables on the in vitro drug release kinetics.
    Ravi PR; Kotreka UK; Saha RN
    AAPS PharmSciTech; 2008; 9(1):302-13. PubMed ID: 18446496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of a sustained-release tablets of metformin hydrochloride using hydrophilic synthetic and hydrophobic natural polymers.
    Wadher KJ; Kakde RB; Umekar MJ
    Indian J Pharm Sci; 2011 Mar; 73(2):208-15. PubMed ID: 22303065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
    Park JB; Lim J; Kang CY; Lee BJ
    Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release matrix uncoated tablets of enalapril maleate using hpmc alone.
    Nair AB; Vyas H; Kumar A
    J Basic Clin Pharm; 2010 Mar; 1(2):71-5. PubMed ID: 24825968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose.
    Ravi PR; Ganga S; Saha RN
    Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):518-24. PubMed ID: 18379101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of Losartan Potassium Controlled Release Matrices and In-Vitro Investigation Using Rate Controlling Agents.
    Khan KA; Khan GM; Muzammal M; Al Mohaini M; Alsalman AJ; Al Hawaj MA; Ahmad A; Niazi ZR; Shah KU; Farid A
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of sustained release opipramol dihydrochloride matrix tablets as a new approach in the treatment of depressive disorders.
    Gönüllü U; Uner M; Yener G; Altınkurt T
    Int J Biomed Sci; 2006 Dec; 2(4):337-43. PubMed ID: 23675002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and Characterization of Hydrophilic Polymer Based Sustained-Release Matrix Tablets of a High Dose Hydrophobic Drug.
    Khan NA; Khan A; Ullah R; Ullah M; Alotaibi A; Ullah R; Haider A
    Polymers (Basel); 2022 May; 14(10):. PubMed ID: 35631868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different polymers and their combinations on the release of metoclopramide HCl from sustained-release hydrophilic matrix tablets.
    Savaşer A; Taş Ç; Bayrak Z; Özkan CK; Özkan Y
    Pharm Dev Technol; 2013; 18(5):1122-30. PubMed ID: 22881478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and in vitro evaluation of oral controlled release formulations of celecoxib using optimization techniques.
    Chandran S; Ravi P; Saha RN
    Yakugaku Zasshi; 2006 Jul; 126(7):505-14. PubMed ID: 16819273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation development and optimization of sustained release matrix tablet of Itopride HCl by response surface methodology and its evaluation of release kinetics.
    Bose A; Wong TW; Singh N
    Saudi Pharm J; 2013 Apr; 21(2):201-13. PubMed ID: 23960836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Carbopol 71G-NF on the release of dextromethorphan hydrobromide from extended-release matrix tablets.
    Fayed MH; Mahrous GM; Ibrahim MA; Sakr A
    Pharm Dev Technol; 2013; 18(5):971-81. PubMed ID: 21639691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on sustained-release metformin hydrochloride from matrix tablet: Influence of hydrophilic polymers and in vitro evaluation.
    Wadher KJ; Kakde RB; Umekar MJ
    Int J Pharm Investig; 2011 Jul; 1(3):157-63. PubMed ID: 23071938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and in vitro evaluation of directly compressed controlled release tablets designed from the Co-precipitates.
    Khan KA; Khan GM; Jan SU; Rehman A; Mehsud S
    Pak J Pharm Sci; 2018 Mar; 31(2):455-461. PubMed ID: 29618434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characterization and release study of Ambroxol hydrochloride matrix tablets prepared by direct compression.
    Abd-Elbary A; Haider M; Sayed S
    Pharm Dev Technol; 2012; 17(5):562-73. PubMed ID: 21428699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
    Quinten T; De Beer T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.